The latest price target for Adient (NYSE:ADNT) was reported by Morgan Stanley on November 14, 2024. The analyst firm set a price target for $19.00 expecting ADNT to fall to within 12 months (a possible -4.14% downside). 29 analyst firms have reported ratings in the last year.

The latest analyst rating for Adient (NYSE:ADNT) was provided by Morgan Stanley, and Adient maintained their underweight rating.

The last upgrade for Adient PLC happened on July 1, 2024 when Exane BNP Paribas raised their price target to $26. Exane BNP Paribas previously had an underperform for Adient PLC.

The last downgrade for Adient PLC happened on April 10, 2024 when Barclays changed their price target from $41 to $37 for Adient PLC.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Adient, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Adient was filed on November 14, 2024 so you should expect the next rating to be made available sometime around November 14, 2025.

While ratings are subjective and will change, the latest Adient (ADNT) rating was a maintained with a price target of $21.00 to $19.00. The current price Adient (ADNT) is trading at is $19.82, which is out of the analyst’s predicted range.